Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: Microarray-based analysis of renal complement components reveals a therapeutic target for lupus nephritis

Fig. 5

Relationships between the levels of TGFβ1 and C3 in LN patients. A Plasma levels of TGFβ1 in SLE patients without LN (N = 26) and patients with LN (N = 25). * p < 0.05. B Correlation of the protein levels of TGFβ1 and C3 in plasma of LN patients (N = 38). C Correlation of the mRNA levels of TGF β1 and C3 in PBMCs of LN patients (N = 18). D Urine levels of TGFβ1 in SLE patients without LN (N = 14) and patients with LN (N = 26). *** p < 0.001. E Correlation between the levels of TGFβ1 and 24 h urine protein in patients with LN (N = 26). F Correlation between the urine levels of TGFβ1 and C3 in LN patients (N = 26). G Immunohistochemical analysis of TGFβ1 and C3 in the glomeruli (GLO) and renal tubules (TUB) of patients with different classes of LN

Back to article page